In order to access this content you must be logged in and have a subscription to PL Intelligence.
PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Medarex acquires ANTI-PSMA antibody rights from Northwest Biotherapeutics
Oncomab and Medarex announce commercial alliance
Northwest and Cytogen sign prostate cancer agreement
Medarex and Eos collaborate to develop human antibodies
Medarex and Ability Biomedical announce alliance
Seattle Cancer Care Alliance to develop first proton-beam therapy center in the Pacific Northwest
Medarex and B. Twelve announce cancer agreement
Diatos and Medarex announce cancer licensing agreement
Northwest Biotherapeutics and Battelle in prostate cancer collaboration
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
